General Mandate: How Singapore Companies Get Pre-Approval to Issue New Shares
Last updated: October 2026
A general mandate is a shareholder-approved authorisation, renewed annually at the AGM, that lets an SGX-listed company’s board issue new shares, usually up to 50% of the existing share base with a 20% non-pro-rata sub-limit, without needing a separate general meeting for each individual issuance. It is the standard mechanism behind most placements and preferential offerings on SGX.
Not financial advice. All figures for educational reference only. Data as at October 2026.
Key Takeaways
- A general mandate is renewed at each AGM and lapses automatically if not refreshed, requiring the board to go back to shareholders annually.
- The typical cap is 50% of issued share capital in total, of which no more than 20% can be issued other than pro-rata (that is, via a placement to selected investors).
- It is used to fund placements, preferential offerings and other share issuances quickly, without the cost and delay of convening an extraordinary general meeting each time.
- Minority shareholders effectively pre-consent to dilution within the approved limits when they vote for the mandate at the AGM.
- A general mandate is different from a specific mandate, which is sought for one particular transaction and requires its own dedicated shareholder vote.
What Is General Mandate?
Every new share issuance by an SGX-listed company generally requires some form of shareholder authorisation under the SGX Listing Manual’s share issue mandate rules. Seeking a fresh, specific shareholder vote for every single issuance would be slow and costly, especially for routine or time-sensitive fundraising. The general mandate solves this by having shareholders approve, once a year at the AGM, a standing authorisation for the board to issue new shares up to defined limits, for whatever purposes the board considers appropriate within those limits, without coming back for a separate vote each time.
How Does General Mandate Work in Singapore?
The general mandate resolution is tabled at the AGM each year, with the company’s circular or notice typically explaining the rationale and intended general use (for example, funding acquisitions, working capital, or capital market opportunities). The standard structure caps total new issuance at 50% of the existing issued share capital, with a further restriction that no more than 20% of that total can be issued on a non-pro-rata basis (typically via a placement to selected investors rather than pro-rata to all shareholders). The mandate lapses at the conclusion of the next AGM unless shareholders vote to renew it again. In practice, boards use general mandates to execute placements, preferential offerings, and scrip-based distributions (such as scrip dividend top-ups) efficiently.
General Mandate Example
A company with 1 billion shares outstanding obtains shareholder approval for a general mandate permitting the board to issue up to 500 million new shares (50% of the existing base), of which up to 200 million (20%) may be issued on a non-pro-rata basis via placement. Later that year, the board decides to raise funds and issues 150 million new shares through a placement to institutional investors, entirely within the mandate’s limits, without needing to call a separate extraordinary general meeting for that specific transaction.
Advantages of General Mandate
- Speed and cost savings for the company. Avoiding an EGM for every issuance saves significant time and administrative cost, letting the board move quickly on fundraising opportunities.
- Flexibility for opportunistic capital raising. A standing mandate lets the board respond to market windows or M&A funding needs without waiting for shareholder approval each time.
- Still bounded by shareholder-approved caps. The 50%/20% limits set a clear ceiling on potential dilution, giving shareholders some protection even without a vote on each individual transaction.
- Annual renewal keeps shareholders informed. Because the mandate must be refreshed every year, shareholders get a regular opportunity to review and, if they choose, vote against it.
Risks and Limitations
- Shareholders pre-approve dilution they can’t individually veto per transaction. Once the mandate is passed, any specific issuance within its limits generally does not require a further shareholder vote, even if some shareholders would have objected to that particular use.
- Non-pro-rata placements can favour selected investors. Shares issued under the 20% non-pro-rata sub-limit go to investors chosen by the board, rather than being offered to all shareholders equally, though pricing discount limits under SGX rules provide some constraint.
- Repeated use compounds dilution over time. A company that renews and fully utilises its general mandate year after year can meaningfully dilute shareholders who don’t participate in each round.
- Disclosure of actual intended use is sometimes general. AGM circulars often describe intended use in broad terms, giving shareholders limited specific insight into exactly how the mandate will be deployed before voting on it.
General Mandate vs Specific Mandate
| Aspect | General Mandate | Specific Mandate |
|---|---|---|
| Approval frequency | Once a year at the AGM, covering multiple future issuances | A dedicated shareholder vote for one particular transaction |
| Speed for a new issuance | Fast — no separate meeting needed if within mandate limits | Slower — requires convening and holding an EGM |
| Dilution cap | 50% of issued capital, 20% non-pro-rata sub-limit (standard structure) | Whatever is specifically proposed and approved for that transaction |
| Typical use case | Routine placements, preferential offerings, scrip issuances | Larger, one-off transactions such as a major acquisition-related share issue |
Source: SGX Listing Manual share issue mandate rules (Mainboard Rule 806 / Catalist Rule 528 framework).
The Bottom Line
For Singapore investors, the general mandate is worth checking every AGM season — voting to renew it hands the board real flexibility to dilute shareholdings within set limits for an entire year, so it’s one of the more consequential routine resolutions that shareholders tend to wave through without close reading.
Frequently Asked Questions
What is a general mandate in Singapore listed companies?
It is a shareholder-approved authorisation, renewed annually at the AGM, that lets the board issue new shares up to defined limits without needing a separate general meeting for each individual issuance.
What is the typical share issuance limit under a general mandate?
The standard structure caps total new issuance at 50% of existing issued share capital, with no more than 20% of that total issued on a non-pro-rata basis.
How often does a general mandate need to be renewed?
It must be renewed at each AGM; if shareholders do not approve a renewal, the mandate lapses and the board loses that standing authorisation.
What is the difference between a general mandate and a specific mandate?
A general mandate covers multiple future issuances within set limits approved once a year, while a specific mandate requires a dedicated shareholder vote for one particular transaction.
Can a company issue shares to anyone it wants under a general mandate's non-pro-rata portion?
The board has discretion over who receives shares under the non-pro-rata sub-limit, typically via placement to selected investors, though SGX rules on pricing discounts provide some constraint on how those shares can be priced.
Why do shareholders vote on a general mandate every year instead of once?
The annual renewal requirement gives shareholders a regular opportunity to review and potentially reject the standing authorisation, rather than granting it indefinitely.
